Vasopressin
MIND · VIII

Vasopressin

Memory consolidation hormone.

From / per milligram
$16$/mg · 2MG
Sizes available
Lab certificate (COA)
Arrives with shipment
View test certificate →

· Research-grade only · Not for human consumption · 21+ ·

What is it

Antidiuretic + memory consolidation hormone (animal/clinical).

Mechanism · Nonapeptide. V1a/V1b/V2 receptors. ADH + memory research.

Who

Best for. Not for.

Best for

  • Memory consolidation research (animal + 1980s human trials)
  • Diabetes insipidus medical use (DDAVP/desmopressin analogue separately)
  • Vasostrict IV for ICU septic-shock vasopressor use (medical professionals only)

Not for

  • Self-administered IV (septic shock indication ICU professionals only)
  • Hyponatremia / water retention risk
  • Coronary artery disease. Vasoconstriction risk
What it does

Mechanism, dose, ramp, risk.

Mechanism
Antidiuretic hormone. Memory consolidation research.Source · PEPVERA editorial
Target dose
10-20 IU, intranasal.Source · PEPVERA editorial
Ramp
On demand.Source · PEPVERA editorial
Risks
Hyponatremia at high doses.Source · PEPVERA editorial
Alternatives

Compared to its siblings.

★ Currently viewing

Vasopressin

Antidiuretic + memory consolidation hormone (animal/clinical).

Pros

  • · Memory consolidation focus, distinct from oxytocin's pro-social bonding.

Cons

  • · Weaker anxiolytic effect than oxytocin.

Oxytocin

Sister nonapeptide. Pro-social bonding focus.

Pros

  • · Anxiolytic effect

Cons

  • · Not memory consolidation

See Oxytocin

How we verify

COA per supplier

Published, in-house, or shipment-time

Each supplier declares its own HPLC floor and COA policy. The per-supplier verifier appears on the certificate page; refund and shipping terms vary by supplier and are shown on the supplier listing.

Suppliers

Compare 0 suppliers

No verified suppliers yet for this compound.

❄ COLD-CHAIN · 5–9 DAYS

Direct from foundry. Slower than domestic resellers; consistency is the trade. Insulated packaging, tracked from departure to doorstep. Replacement issued on damage.

Dosing protocol

Week 1–2

10-20 IU, intranasal.

Initiation

Week 3–4

10-20 IU, intranasal.

Signal emerges

Week 5–8

10-20 IU, intranasal.

Hold

Week 9–12

Cycle review

Assess

Reconstitution

Draw 20 units.

0.2 mg = 0.20 mL at 1.00 mg/mL. 10.0 doses per vial.

mind · VIII

Vasopressin · 2mg